Home/ Supplements/ Vitamin K/ Bone Restore with Vitamin K2

Bone Restore with Vitamin K2

product on market Capsule Life Extension Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 62% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Calcium, magnesium, and zinc provide essential mineral support for bone structure, while vitamins D3 and K2 facilitate calcium absorption and distribution. Strong clinical evidence supports the synergistic role of these nutrients in maintaining bone mineral density. The ingredient profile is associated with a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Bone Restore with Vitamin K2
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Multi-Vitamin and Mineral (MVM)
Product Type
62%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25 mcg (125% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
200 mcg (167% DV)
1.7× RDA — within safe limits 275 studies (A:9, B:175)
Calcium
700 mg (54% DV)
300 mg (71% DV)
Within RDA (0.7× RDA) 316 studies (A:8, B:159)
2 mg (18% DV)
Within RDA (0.2× RDA) 263 studies (A:6, B:134)
1 mg (43% DV)
Within RDA (0.4× RDA) 9 studies — no high-quality reviews
5 mg
Market median: 108.0mg (8 products) 9 studies (A:0, B:4)
3 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews

Other Ingredients

Cellulose Microcrystalline Cellulose Stearate Maltodextrin Silica Food Starch, Modified
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take four (4) capsules daily, or as recommended by a healthcare practitioner. Scientific studies suggest calcium supplementation in divided doses with food in the morning and evening may yield the best results.

Warnings & Precautions

Read the entire label and follow the directions carefully.

Caution: If you are taking a vitamin K antagonist (e.g. warfarin), consult your healthcare practitioner before taking this product.

Warnings: Keep out of reach of children.

Do not exceed recommended dose. Do not purchase if outer seal is damaged.

Consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

To report a serious adverse event or obtain product information, contact 1-866-280-2852.

Formulation Notes

Maintaining an optimal vitamin D blood level also helps maximize calcium absorption.

Gluten free Non GMO LE Certified

Super calcium formula

Additional Information

Scan for product info

Store tightly closed in a cool, dry place.

Non GMO LE Certified

Metadata

Product Details

UPC / SKU7 37870 17271 0
DSLD Entry Date2025-03-25
Product TypeMulti-Vitamin and Mineral (MVM)
FormCapsule
DSLD ID328299
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.